Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Connexion
Les utilisateurs de lecteurs d'écran peuvent cliquer sur ce lien pour activer le mode d'accessibilité. Celui-ci propose les mêmes fonctionnalités principales, mais il est optimisé pour votre lecteur d'écran.

Brevets

  1. Recherche avancée dans les brevets
Numéro de publicationUS6822253 B1
Type de publicationOctroi
Numéro de demandeUS 10/434,796
Date de publication23 nov. 2004
Date de dépôt9 mai 2003
Date de priorité9 mai 2003
État de paiement des fraisPayé
Autre référence de publicationUS7019317
Numéro de publication10434796, 434796, US 6822253 B1, US 6822253B1, US-B1-6822253, US6822253 B1, US6822253B1
InventeursMatthew R. Martin, Kenneth A. Paladino
Cessionnaire d'origineBiodex Medical Systems, Inc.
Exporter la citationBiBTeX, EndNote, RefMan
Liens externes: USPTO, Cession USPTO, Espacenet
Radiopharmaceutical shipping pig with encapsulated lead shielding
US 6822253 B1
Résumé
Encapsulation of an inner facing surface of a lead shield of a radiopharmaceutical pig. The inner facing surface defines a chamber in which is inserted a radiopharmaceutical syringe. The encapsulation protects the inner facing surface against contamination due to leaks of the contents of the radiopharmaceutical syringe and further obviates the need for a sharps container to enclose the syringe during transport.
Images(4)
Previous page
Next page
Revendications(24)
What is claimed is:
1. A radiopharmaceutical pig apparatus, comprising:
two case halves secured to each other and defining a cavity;
two lead shields that define a chamber, the two lead shields being within the cavity, each lead shield being secured to a respective one of the two case halves; and
at least one liner encapsulating and sealing an inner facing surface of at least one of the two lead shields, the inner facing surface defining a portion of the chamber, the liner being adhered to the inner facing surface with an adhering material, the chamber being configured to accommodate maintaining a radiopharmaceutical syringe in a stationary position within the confines of the chamber.
2. A radiopharmaceutical pig apparatus as in claim 1, further comprising the syringe within the confines of the chamber.
3. An apparatus of claim 1, wherein the adhering material is selected from a group consisting of a glue, an epoxy, and a laminate.
4. A radiopharmaceutical pig apparatus as in claim 1, further comprising a further liner encapsulating and sealing a further inner facing surface of the other of the two lead shields, the further inner facing surface defining a further portion of the chamber.
5. A radiopharmaceutical pig apparatus as in claim 1, wherein the two case halves have screw threads that engage each other to effect a screw thread engagement between the two case halves.
6. A radiopharmaceutical pig apparatus as in claim 4, further comprising an O-ring between the first-mentioned liner and the further liner, each of the first-mentioned liner and the further liner having outwardly directed flange surfaces between which is sandwiched the O-ring.
7. A radiopharmaceutical pig apparatus as in claim 1, wherein one of the case halves has a cylindrical exterior with a series of flat surfaces spaced apart from each other about a circumference of the cylindrical exterior.
8. A radiopharmaceutical pig apparatus as in claim 1, wherein the two lead shields are elongated and each have edges that face each other, the edges being configured to overlap and engage each other to prevent radiation leakage.
9. An apparatus of claim 1, wherein the two lead shields each have an outwardly extending flange with a further surface that faces opposite each other clear of the chamber, the liner encapsulating the surface of the at least one of the two lead shields.
10. A radiopharmaceutical pig apparatus, comprising:
two case halves secured to each other and defining a cavity;
two lead shields that define a chamber, the two lead shields being within the cavity, each lead shield being secured to a respective one of the two case halves; and
at least one liner encapsulating and sealing an inner facing surface of at least one of the two lead shields, the inner facing surface defining a portion of the chamber, the chamber being configured to accommodate maintaining a radiopharmaceutical syringe in a stationary position within confines of the chamber the liner is being heat sealed.
11. A radiopharmaceutical pig apparatus, comprising:
two case halves secured to each other and defining a cavity;
two lead shields that define a chamber, the two lead shields being within the cavity each lead shield being secured to a respective one of the two case halves; and
at least one liner encapsulating and sealing an inner facing surface of at least one of the two lead shields, the inner facing surface defining a portion of the chamber, the chamber being configured to accommodate maintaining a radiopharmaceutical syringe in a stationary position within confines of the chamber; and a syringe within the confines of the first-mentioned chamber and the further chamber, the syringe being free of any sharps container.
12. An apparatus of claim 11, wherein the liner is securely attached with a material selected from a group consisting of a glue, an epoxy, a laminate and heat sealing materials.
13. An apparatus of claim 11, wherein the two lead shields each have an outwardly extending flange with a further surface that faces opposite each other clear of the chamber, the liner encapsulating the face of the at least one of the two lead shields.
14. A radiopharmaceutical pig apparatus, comprising:
two case halves secured to each other and defining a cavity;
two lead shields that define a chamber, the two lead shields being within the cavity, each lead shield being secured to a respective one of the two case halves; and
at least one liner encapsulating and sealing an inner facing surface of at least one of the two lead shields, the inner facing surface defining a portion of the chamber, the chamber being configured to accommodate maintaining a radiopharmaceutical syringe in a stationary position within confines of the chamber; one of the case halves having a bottom projection having at least one corner, which, when engaged, prevents the one of the case halves from rotating in unison with the other of the case halves.
15. A method of providing a radiopharmaceutical pig, comprising:
encapsulating and sealing an inner facing surface of a lead shield with a liner;
confining the lead shield and a further lead shield within a cavity defined by two case halves, each of the lead shield and the further lead shield being secured to a respective one of the two case halves, the lead shield and the further lead shield each defining a chamber a portion of which being bounded by the inner facing surface encapsulated by the liner;
inserting within the chamber a radiopharmaceutical syringe that is free of any sharps container; and
securing the two case halves to each other.
16. A method as in claim 15, wherein the inserting includes placing a portion of the radiopharmaceutical syringe within the portion of the chamber that is bounded by the inner facing surface encapsulated by the liner, and accommodating a remaining portion of the radiopharmaceutical syringe in a remainder of the chamber.
17. A method as in claim 15, further comprising encapsulating the further lead shield with a further liner.
18. A method of claim 15, further comprising securely attaching the liner with a material selected from a group consisting of glue, an epoxy, a laminate and heat sealing materials.
19. A method of claim 15, wherein the two lead shields each have an outwardly extending flange with a further surface that faces opposite each other clear of the chamber, further comprising encapsulating the face of at least one of the two lead shields with the liner.
20. A method as in claim 15, further comprising preventing the two case halves from rolling along a flat surface although the case halves each have an cylindrical exterior by providing flats spaced apart from each other about a circumference of the cylindrical exterior of at least one of the two case halves.
21. A method as in claim 15, further comprising adhering the liner to the inner facing surface.
22. A method of providing a radiopharmaceutical pig, comprising:
encapsulating and sealing an inner facing surface of a lead shield with a liner;
confining the lead shield and a further lead shield within a cavity defined by two case halves, each of the lead shield and the further lead shield being secured to a respective one of the two case halves, the lead shield and the further lead shield each defining a chamber a portion of which being bounded by the inner facing surface encapsulated by the liner;
securing the two case halves to each other; and engaging a projection at a bottom of one of the two case halves so as to prevent rotation of the one of two case halves in unison with the other of the two case halves; the projection having at least one corner, and rotating the other of the two case halves relative to the one of the two case halves to either tighten or loosen the two case halves from each other.
23. A method of providing a radiopharmaceutical pig, comprising:
encapsulating and sealing an inner facing surface of a lead shield with a liner;
confining the lead shield and a further lead shield within a cavity defined by two case halves, each of the lead shield and the further lead shield being secured to a respective one of the two case halves, the lead shield and the further lead shield each defining a chamber a portion of which being bounded by the inner facing surface encapsulated by the liner;
securing the two case halves to each other, and heat sealing the liner.
24. A method of providing a radiopharmaceutical pig, comprising:
encapsulating and sealing an inner facing surface of a lead shield with a liner;
confining the lead shield and a further lead shield within a cavity defined by two case halves, each of the lead shield and the further lead shield being secured to a respective one of the two case halves, the lead shield and the further lead shield each defining a chamber a portion of which being bounded by the inner facing surface encapsulated by the liner; and
securely attaching the liner with a material selected from a group consisting of glue, an epoxy, a laminate and heat sealing materials, the cavity being free of a sharps container.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates to shipping pigs for radiopharmaceuticals that use lead for radiation shielding. In particular, lead shielding between outer cases and inner plastic liners are enclosed and sealed.

2. Discussion of the Prior Art

Conventional shipping pigs for radiopharmaceuticals includes those that use lead for radiation shielding. Some have removable inner liners to hold the syringes containing the radiopharmaceutical. Such inner liners are inserted with outer cases of the radiopharmaceutical pigs.

It would therefore be desirable to provide a radiopharmaceutical pig that encloses and seals lead shielding between outer cases and inner plastic liners.

SUMMARY OF THE INVENTION

One aspect of the invention resides in encapsulation of an inner facing surface of a lead shield of a radiopharmaceutical pig. The inner facing surface defines a chamber in which is inserted a radiopharmaceutical syringe. The encapsulation protects the inner facing surface against contamination due to leaks of the contents of the radiopharmaceutical syringe and further obviates the need for a sharps container to enclose the syringe.

BRIEF DESCRIPTION OF THE DRAWING

For a better understanding of the present invention, reference is made to the following description and accompanying drawings, while the scope of the invention is set forth in the appended claims.

FIG. 1 shows a longitudinal cutaway view of a radiopharmaceutical pig in accordance with the invention.

FIG. 2 is an exploded view thereof.

FIG. 3 is an elevation side view thereof.

DETAILED DESCRIPTION OF THE DRAWING

Turning to the drawings, FIGS. 1 and 2 identify lower assembly components, namely, a lower case 1, a lower lead shield 2, a lower liner 3, and an O-ring 4, all which may be collectively considered part of a lower assembly 13. FIGS. 1 and 2 also identify upper assembly components, namely, an upper lead shield 5, an upper liner 6 and an upper case 7, all which may collectively be considered part of an upper assembly 14.

The lower case 1 may be made of plastic, metal or a combination of each. The lower lead shield 2 is securely attached to the lower case 1, such as with glue, epoxy, a laminate or heat sealing materials. A lower liner 3 is likewise securely attached to the lower lead shield 2 with an encapsulating material, such as with glue, epoxy, a laminate, or heat sealing materials, so that an inner facing surface of the lower lead shield 2 is completely covered and sealed, i.e., encapsulated by the lower liner 3. The O ring 4, which may be made of neoprene or other elastomer, is securely attached into a groove 8, such as with glue or epoxy. The groove 8 may be formed to accommodate the way that the lower liner 3 fits with the lower case 1.

The upper case 7 may be made of plastic, metal or a combination of both. The upper lead shield 6 is securely attached to the upper case 7, such as with glue or heat sealing materials. The upper liner 5 is securely attached to the upper lead shield 6 with an encapsulating material, such as glue, epoxy, a laminate or heat sealing materials, so that the lead of the upper lead shield 6 is completely covered and sealed, i.e., encapsulated.

The O-ring 4 seals the lower liner 3 to the upper liner 5 as the upper assembly 14 is screwed onto the lower assembly 13 using the threads 9. Each of the lower line 3 and the upper liner 5 may have outwardly directed flange surfaces that sandwich the O-ring 4 between them to seal a chamber defined by the lower and upper liners 3, 5. The threads 9 may be triple start threaded to reduce an amount of turns needed to screw the two assemblies 13, 14 together.

In addition, the lower case 1 has flats 11 that are molded to prevent the lower assembly 13 from rolling on a flat surface. There may be a configuration with at least one corner such as a hexagon shape 12 molded onto the bottom of the lower case 1 such that the hexagon shape 12 can be secured in a hexagon shaped hole or recess. This way the upper assembly 14 can be screwed to, or unscrewed from, the lower assembly 13 without the user holding onto the lower assembly. This greatly reduces the amount and duration of hand exposure to radiation, because the user no longer needs to hold onto the lower assembly during the screwing and unscrewing operations.

The syringe 10 contains a radiopharmaceutical and is placed into the lower liner 3 before the two halves of the upper and lower cases 1, 7 are screwed together by engaging thread connections. After the two halves have been screwed together, the syringe 10 is shipped filled within the two halves to a site. After arrival at the site, the syringe is removed from the two halves and used to administer the radiopharmaceutical from the syringe. When done, the empty syringe is replaced in the pig and then shipped back empty.

The two lead shields 2, 6 have edges that face each other that are configured to overlap and engage each other so as to completely shield against penetration of radiation at the joint between the two lead shields 2, 6. Thus, lower lead shield 2 may have a tubular projection in the edge that complements, but is of a reduced diameter, than a further tubular projection in the edge of the upper lead shield 5. The lower lead shield 2 may have a lower projection that fits within a complementary recess inside at the base of the lower case 1,

As a result of encapsulating, the lower and upper lead shields 2, 6 are sealed and thereby protected by the lower and upper liners 3, 5 against contamination from any radiopharmaceutical remnants from the syringe 10 and against exposing the lead shields to cleansing fluids such as water when cleaning them. The lower and upper lines 3, 5 may be formed of plastic or metal material.

The syringe 10 may be entirely free of any sharps container surrounding it, because the lower and upper liners 3, 5 obviate the need for it. Indeed, a sharps container would not need to be used in the radiopharmaceutical pig of the present invention to provide sufficient protection of the lead shields against contamination by the discharge of any remnants from within the syringe 10, because the encapsulation provides sufficient protection. The lower and upper liners 3, 5 themselves may be formed of an encapsulating material that adheres or otherwise clings to secure itself to the lead shield to which it is in contact, such as when subjected to a sufficient amount of heat.

While the foregoing description and drawings represent the preferred embodiments of the present invention, it will be understood that various changes and modifications may be made without departing from the spirit and scope of the present invention.

Citations de brevets
Brevet cité Date de dépôt Date de publication Déposant Titre
US5519931 *16 mars 199428 mai 1996Syncor International CorporationContainer and method for transporting a syringe containing radioactive material
US6162198 *11 juin 199719 déc. 2000Syncor International CorporationInjection shield and method for discharging a syringe containing radioactive material
US6425174 *23 oct. 200030 juil. 2002Syncor International Corp.Container and method for transporting a syringe containing radioactive material
US6576918 *9 août 200010 juin 2003Syncor International Corp.Container and method for transporting a syringe containing radioactive material
US6586758 *11 juin 20011 juil. 2003Biodex Medical Systems, Inc.Radiopharmaceutical pig and transportation apparatus
US20020178566 *12 juil. 20025 déc. 2002Reich Don E.Container and method for transporting a syringe containing radioactive material
US20020195575 *11 juin 200126 déc. 2002Martin Matthew R.Radiopharmaceutical pig and transportation apparatus
US20030222228 *4 déc. 20024 déc. 2003Chen Fu Monty MongApparatus and method for transporting radiopharmaceuticals
USRE36693 *9 avr. 199816 mai 2000Syncor InternationalRadiopharmaceutical pig having an inner chamber in which a sharps container can be secured. the sharps container has a housing and an attachable cap.
Référencé par
Brevet citant Date de dépôt Date de publication Déposant Titre
US7268359 *18 juil. 200511 sept. 2007Cardinal Health, Inc.Apparatus and method for transporting radiopharmaceuticals
US730726523 sept. 200511 déc. 2007United Pharmacy Partners, Inc.Three section pig for radio-pharmaceuticals
US741425428 juin 200519 août 2008United Pharmacy Partners, Inc.Tungsten pig for radio-pharmaceuticals
US74739187 déc. 20056 janv. 2009Vulcan Global Manufacturing Solutions, Inc.Radiation-shielding container
US749524613 juil. 200624 févr. 2009Mallinckrodt, Inc.Radiopharmaceutical pig
US781232226 juil. 200612 oct. 2010Mallinckrodt Inc.Radiation-shielding assemblies and methods
US8269201 *10 oct. 200618 sept. 2012Mallinckrodt LlcRadiopharmaceutical pig
Classifications
Classification aux États-Unis250/507.1, 250/506.1, 250/515.1, 53/449, 206/364, 250/505.1
Classification internationaleG21K1/00, G21F5/00, G21F5/018
Classification coopérativeG21Y2002/304, G21F5/018, G21Y2004/30, G21Y2002/207
Classification européenneG21F5/018
Événements juridiques
DateCodeÉvénementDescription
23 mai 2012FPAYFee payment
Year of fee payment: 8
23 mai 2008FPAYFee payment
Year of fee payment: 4
9 mai 2003ASAssignment
Owner name: BIODEX MEDICAL SYSTEMS, INC., NEW YORK
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MARTIN, MATTHEW R.;PALADINO, KENNETH A.;REEL/FRAME:014065/0827
Effective date: 20030506
Owner name: BIODEX MEDICAL SYSTEMS, INC. 20 RAMSEY ROAD, BOX 7
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MARTIN, MATTHEW R. /AR;REEL/FRAME:014065/0827